300158 振東製藥
按盤價 
3.880 +0.260 (+7.182%)
3.880 +0.260 (+7.182%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.596 | -0.843 | -0.769 | 38.143 | 4.729 |
| 總資產報酬率 ROA (%) | 0.507 | -0.691 | -0.616 | 29.581 | 3.610 |
| 投入資產回報率 ROIC (%) | 0.578 | -0.807 | -0.728 | 34.670 | 4.229 | 邊際利潤分析 |
| 銷售毛利率 (%) | 49.531 | 50.375 | 49.314 | 59.667 | 62.234 |
| 營業利潤率 (%) | 2.949 | -0.827 | -0.159 | 61.282 | 6.729 |
| 息稅前利潤/營業總收入 (%) | 2.625 | -1.303 | 0.126 | 61.457 | 7.042 |
| 淨利潤/營業總收入 (%) | 1.865 | -1.320 | -1.529 | 51.232 | 5.231 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -49.552 | 401.713 | 3,667.027 | 2.700 | 79.911 |
| 價值變動淨收益/利潤總額(%) | 87.801 | -119.491 | -1,250.833 | 94.803 | 4.332 |
| 營業外收支淨額/利潤總額(%) | -8.988 | 20.453 | -12.118 | -0.175 | -1.041 | 償債能力分析 |
| 流動比率 (X) | 5.198 | 4.864 | 4.038 | 4.680 | 2.237 |
| 速動比率 (X) | 3.744 | 3.560 | 3.150 | 4.159 | 1.753 |
| 資產負債率 (%) | 14.403 | 16.769 | 20.266 | 20.201 | 0.259 |
| 帶息債務/全部投入資本 (%) | 1.265 | 1.211 | 2.893 | 4.074 | 9.563 |
| 股東權益/帶息債務 (%) | 7,696.153 | 7,972.653 | 3,282.543 | 2,314.544 | 903.707 |
| 股東權益/負債合計 (%) | 598.448 | 499.702 | 395.756 | 396.256 | 286.540 |
| 利息保障倍數 (X) | -32.788 | 4.940 | 0.471 | 218.054 | 18.409 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 73.946 | 66.030 | 76.499 | 71.145 | 82.872 |
| 存貨周轉天數 (天) | 275.911 | 227.064 | 191.597 | 154.396 | 139.506 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
